Index of reports
> Cases with General Physical Health Deterioration (62)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Optimark (Gadoversetamide) where reactions include general physical health deterioration. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 62 Next >>
Possible Optimark side effects in 49 year old male
Reported by a lawyer from United States on 2012-08-02
Patient: 49 year old male, weighing 77.1 kg (169.6 pounds)
Reactions: Pain, Joint Contracture, Erythema, Muscle Tightness, Joint Stiffness, Myosclerosis, Rash Pruritic, Joint Range of Motion Decreased, Skin Lesion, Oedema Peripheral, Musculoskeletal Stiffness, Oedema, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Skin Tightness, Skin Plaque, Joint Swelling, Quadriparesis, Mobility Decreased
Drug(s) suspected as cause:
Omniscan
Multihance
Indication: Product Used FOR Unknown Indication
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-05-19
End date: 2006-05-19
Magnevist
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-10-13
End date: 2006-10-13
Omniscan
Dosage: 50 ml omniscan+co2
Indication: Fistulogram
Start date: 2006-08-04
End date: 2006-08-04
Gadolinium IN Unspecified Drug
Start date: 2004-05-19
End date: 2004-05-19
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-08-05
End date: 2006-08-05
Prohance
Indication: Computerised Tomogram Head
Start date: 2004-05-19
End date: 2004-05-19
Optimark
Indication: Product Used FOR Unknown Indication
Magnevist
Dosage: 20 ml, unk
Start date: 2006-10-17
End date: 2006-10-17
Other drugs received by patient: Coumadin; Renagel; Aranesp; Lyrica; Norvasc; Lamisil; Percocet; Gentamicin; Procardia XL; Ferrous Sulfate TAB; Sodium Bicarbonate; Acetaminophen; Venofer; Coreg; Actos; Prinivil; Synthroid; Amitriptline Hydrochloride TAB; Nateglinide; Pentoxifylline; Phoslo; Procrit; Epogen; Nexium; Elavil; Lipitor; Lantus; Trental; Benadryl; Avelox; Pletal; Tambocor; Atenolol; Zyvox; Lopid; Nephrocaps; Bactrim DS; Restoril; Clonidine; Starlix; Accupril; Vancomycin; Lasix; Potassium Chloride; Glucotrol; Renagel; Nicotine
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient: 56 year old female
Reactions: Pruritus, Abasia, Pain, Joint Contracture, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Rash, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Mobility Decreased, Scar
Drug(s) suspected as cause:
Optimark
Indication: Muscular Weakness
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Magnevist
Indication: Renal Mass
Other drugs received by patient: Lantus; Sensipar; Slow Release Iron; Prograf; Phoslo; Renvela; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone; Procrit; Atenolol
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: female
Reactions: Pruritus, Pain, Joint Contracture, Myosclerosis, Skin Ulcer, Injury, Fibrosis, General Physical Health Deterioration, Skin Hypertrophy, Skin Induration, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Tendon Disorder, Disability
Drug(s) suspected as cause:
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Angiogram
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Angiogram
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-27
Patient: female
Reactions: Pruritus, Pain, Muscle Contracture, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Plaque, Emotional Distress, Anxiety, Skin Ulcer, Arthralgia, Fibrosis, Injury, Disability
Drug(s) suspected as cause:
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Angiogram
Magnevist
Indication: Angiogram
Multihance
Indication: Angiogram
Omniscan
Indication: Angiogram
Optimark
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Joint Stiffness, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Fibrosis, Injury, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, DRY Skin, Nephrogenic Systemic Fibrosis, Rash, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Pigmentation Disorder, Scar, Mobility Decreased
Drug(s) suspected as cause:
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Optimark
Indication: Headache
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Magnevist
Indication: Renal Mass
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2004-05-21
End date: 2004-05-21
Other drugs received by patient: Sensipar; Renvela; Prograf; Prednisone; Procrit; Phoslo; Lantus; Slow Release Iron; Atenolol; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]
Possible Optimark side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Pruritus, Hyperkeratosis, Pain, Skin Burning Sensation, Skin Hyperpigmentation, Erythema, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Skin Lesion, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Hypoaesthesia, Skin Induration, Deformity, Skin Tightness, Paraesthesia, Skin Plaque, Rash Macular, Gait Disturbance, Scar, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2004-10-15
End date: 2004-10-15
Prohance
Dosage: 17 ml, once
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2003-07-03
End date: 2003-07-03
Magnevist
Omniscan
Dosage: 30 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-13
End date: 2004-07-13
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-04-14
End date: 2005-04-14
Omniscan
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Optimark
Multihance
Other drugs received by patient: Calcitriol; Plavix; Fosrenol; Sensipar; Clonidine; Renvela; Rena-Vite; Calcium Carbonate; Metoprolol Tartrate; Renagel; Cozaar; Phoslo; Epogen; Hectorol; Iron; Amlodipine; Lisinopril; Proamatine; Foltx
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-01
Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)
Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Skin Hyperpigmentation, Scleroderma, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Rash Papular, General Physical Health Deterioration, Skin Induration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Skin Plaque, Sclerodactylia, Skin Tightness, Macule, Mobility Decreased
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-13
End date: 1999-10-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-03-21
End date: 2007-03-21
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-11-18
End date: 2008-11-18
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-28
End date: 1999-10-28
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-14
End date: 2006-01-14
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-09-20
End date: 1999-09-20
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Fistulogram
Start date: 1999-10-08
End date: 1999-10-08
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-04
End date: 2006-02-04
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-03-19
End date: 2008-03-19
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-09-27
End date: 1999-09-27
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-08-13
End date: 2008-08-13
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Aspirin; Hydrocodone Bitartrate + Acetaminophen; Phoslo; Calcium Acetate; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Iron; Renvela
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: 56 year old female
Reactions: Joint Contracture, Pain, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Depression, Injury, Extremity Contracture, Muscular Weakness, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Headache
Optimark
Indication: Muscular Weakness
Other drugs received by patient: Renvela; Prednisone; Lantus; Sensipar; Atenolol; Prograf
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: 56 year old female
Reactions: Pruritus, Abasia, Joint Contracture, Pain, Skin Hyperpigmentation, Ephelides, Joint Stiffness, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Depression, Fibrosis, Extremity Contracture, Pain in Extremity, Musculoskeletal Pain, Muscle Contracture, Muscular Weakness, General Physical Health Deterioration, Skin Disorder, Skin Induration, Nephrogenic Systemic Fibrosis, Rash, DRY Skin, Skin Tightness, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Magnevist
Indication: Renal Mass
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Muscular Weakness
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-05-28
End date: 1999-05-28
Other drugs received by patient: Lantus; Sensipar; Phoslo; Procrit; Renvela; Prograf; Atenolol; Slow Release Iron; Nephrovite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Prednisone TAB
Possible Optimark side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)
Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Skin Discolouration, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Arthralgia, Gait Disturbance, Skin Fibrosis, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Magnevist
Dosage: 30 ml, once
Start date: 2000-05-05
End date: 2000-05-05
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Start date: 2006-07-14
End date: 2006-07-14
Magnevist
Dosage: 48 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-02-05
End date: 2000-02-05
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-12-17
End date: 2001-12-17
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 39 ml, once
Start date: 2006-07-26
End date: 2006-07-26
Unspecified Gadolinium Based Contrast Agent
Indication: Angiogram
Start date: 2000-10-01
End date: 2000-10-15
Magnevist
Dosage: 40 ml, once
Start date: 2006-08-09
End date: 2006-08-09
Other drugs received by patient: Prednisone; Imuran; Norvasc; Calcium Carbonate; Micardis; Oxycet; Darbepoetin Alfa; Minoxidil; Percocet; Renagel; Digoxin; Clonidine; Phoslo; Lanthanum Carbonate; Ferrlecit; Florinef; Lopressor; Plaquenil; Procardia; Zemplar; Coreg; Amiodarone HCL; Aspirin; Cortisone Acetate; Renaphro; Epogen; Vancomycin; Darbepoetin Alfa; Hectorol; Fosrenol
Possible Optimark side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-18
Patient: 50 year old male, weighing 69.8 kg (153.6 pounds)
Reactions: Muscle Contractions Involuntary, Pain, Skin Hyperpigmentation, Joint Stiffness, Joint Range of Motion Decreased, Skin Discolouration, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Muscular Weakness, General Physical Health Deterioration, Skin Hypertrophy, Nephrogenic Systemic Fibrosis, Skin Induration, Arthralgia, Gait Disturbance, Mobility Decreased, Skin Fibrosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Unspecified Gadolinium Based Contrast Agent
Indication: Angiogram
Start date: 2000-10-01
End date: 2000-10-15
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-12-17
End date: 2001-12-17
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 48 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2000-02-05
End date: 2000-02-05
Magnevist
Dosage: 39 ml, once
Start date: 2006-07-26
End date: 2006-07-26
Magnevist
Dosage: 30 ml, once
Start date: 2000-05-05
End date: 2000-05-05
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 40 ml, once
Start date: 2006-08-09
End date: 2006-08-09
Unspecified Gadolinium Based Contrast Agent
Dosage: unk
Start date: 2006-07-14
End date: 2006-07-14
Other drugs received by patient: Epogen; Renagel; Procardia; Aspirin; Lopressor; Minoxidil; Ferrlecit; Zemplar; Coreg; Norvasc; Calcium Carbonate; Lanthanum Carbonate; Renaphro; Imuran; Digoxin; Florinef; Cortisone Acetate; Plaquenil; Micardis; Amiodarone HCL; Darbepoetin Alfa; Prednisone; Hectorol; Vancomycin; Darbepoetin Alfa; Phoslo; Fosrenol; Clonidine; Percocet; Oxycet
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-16
Patient: 56 year old female
Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Injury, Fibrosis, Depression, Extremity Contracture, Skin Disorder, Muscular Weakness, General Physical Health Deterioration, DRY Skin, Nephrogenic Systemic Fibrosis, Skin Induration, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Indication: Renal Mass
Optimark
Indication: Muscular Weakness
Optimark
Indication: Disorientation
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-06-02
End date: 2006-06-02
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-05-21
End date: 2004-05-21
Other drugs received by patient: Sensipar; Atenolol; Prednisone TAB; Prograf; Renvela; Lantus
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-15
Patient: 56 year old female
Reactions: Pain, Abasia, Joint Contracture, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Fibrosis, Injury, Depression, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Nephrogenic Systemic Fibrosis, Skin Induration, DRY Skin, Deformity, Skin Tightness, Emotional Distress, Anxiety, Arthralgia, Dermal Cyst, Scar, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Headache
Optimark
Indication: Disorientation
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Muscular Weakness
Other drugs received by patient: Lantus; Sensipar; Prednisone; Atenolol; Prograf; Renvela
Possible Optimark side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14
Patient: 64 year old male
Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Emotional Distress, Anxiety, Skin Lesion, Injury, Mobility Decreased
Drug(s) suspected as cause:
Omniscan
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Omniscan
Start date: 2003-02-27
End date: 2003-02-27
Magnevist
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Magnevist
Start date: 2003-02-27
End date: 2003-02-27
Prohance
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Product Used FOR Unknown Indication
Multihance
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Lanoxin; Coumadin; Nitroglycerin; Metoprolol Tartrate
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02
Patient: 56 year old female
Reactions: Pain, Joint Contracture, Abasia, Skin Hyperpigmentation, Ephelides, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Musculoskeletal Stiffness, Depression, Injury, Fibrosis, Extremity Contracture, General Physical Health Deterioration, Muscular Weakness, Skin Disorder, Skin Induration, DRY Skin, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Skin Plaque, Anxiety, Emotional Distress, Arthralgia, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Disorientation
Optimark
Indication: Muscular Weakness
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Headache
Other drugs received by patient: Prograf; Sensipar; Prednisone; Atenolol; Renvela; Lantus
Possible Optimark side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30
Patient: 43 year old male, weighing 118.0 kg (259.6 pounds)
Reactions: Pain in Extremity, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Deformity, Skin Tightness, Emotional Distress, Anxiety, Skin Discolouration, Fibrosis, Depression, Mobility Decreased, Scar
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Omniscan
Dosage: 20 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-04-25
End date: 2006-04-25
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Dosage: 20 ml, once
Start date: 2006-05-21
End date: 2006-05-21
Other drugs received by patient: Nephrocaps; Losartan Potassium; Aldactone; Insulin; Albumin (Human); Cardizem; Zemplar; Procardia XL; Aranesp; Catapres; Procrit; Phoslo
Possible Optimark side effects in 64 year old male
Reported by a lawyer from United States on 2012-04-19
Patient: 64 year old male
Reactions: Rash Generalised, Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Anxiety, Emotional Distress, Skin Lesion, Injury, Mobility Decreased
Drug(s) suspected as cause:
Omniscan
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Magnevist
Start date: 2003-02-27
End date: 2003-02-27
Multihance
Indication: Product Used FOR Unknown Indication
Magnevist
Indication: Product Used FOR Unknown Indication
Start date: 2001-01-31
End date: 2001-01-31
Omniscan
Start date: 2003-02-27
End date: 2003-02-27
Prohance
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Nitroglycerin; Lanoxin; Coumadin; Metoprolol Tartrate
Possible Optimark side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11
Patient: 61 year old male, weighing 160.9 kg (354.0 pounds)
Reactions: Thrombosis, Visual Acuity Reduced, Skin Hyperpigmentation, Hyperhidrosis, Dermatitis, Oedema Peripheral, Back Pain, Pain in Extremity, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Induration, Hypoaesthesia, Deformity, Tremor, Anxiety, Arthralgia, Scar
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2001-03-02
End date: 2001-03-02
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Brain
Magnevist
Dosage: unk unk, once
Indication: Renal Mass
Start date: 2004-03-29
End date: 2004-03-29
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Back Pain
Prohance
Indication: Imaging Procedure
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2006-02-22
End date: 2006-02-22
Multihance
Indication: Imaging Procedure
Other drugs received by patient: Warfarin Sodium; Bextra; Celebrex; Prilosec; Dynacirc; Testosterone; Vitamin B12 NOS; Ibuprofen; Flomax; Water Purified; Lortab; Viagra; NTP; Hydrochlorothiazide; Dovonex; Avapro; Prevacid; Vitamin B6; Aspirin
Possible Optimark side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-11
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Renal Disorder, Pain, Skin Disorder, General Physical Health Deterioration, Rash, Nephrogenic Systemic Fibrosis, Discomfort, Emotional Distress, Anxiety, Major Depression, Injury, Immobile, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: 19 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-21
End date: 2008-07-21
Gadolinium IN Unspecified Drug
Indication: Angiogram
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-11
End date: 2005-08-11
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-21
End date: 2005-05-21
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Dizziness
Start date: 2006-10-23
End date: 2006-10-23
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Asthenia
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Lyrica; Tamsulosin HCL; Dexamethasone; Warfarin Sodium; Silodosin; Amiodarone HCL; Norvasc; Actonel; Triamteren HCT; Hydralazine HCL; Iron Sulfatethiamin Compound TAB; Metoprolol Tartrate; Benicar; Omeprazole; Coreg; Metformin HCL; Simvastatin; Potassium
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-11
Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)
Reactions: Hyperkeratosis, Skin Exfoliation, Pain, Joint Contracture, Scleroderma, Skin Hyperpigmentation, Erythema, Joint Range of Motion Decreased, Oedema Peripheral, Skin Swelling, Papule, General Physical Health Deterioration, Skin Induration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, DRY Skin, Deformity, Skin Plaque, Skin Tightness, Sclerodactylia, Macule
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-14
End date: 2006-01-14
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-28
End date: 1999-10-28
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-08-13
End date: 2008-08-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-11-18
End date: 2008-11-18
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-09-20
End date: 1999-09-20
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-03-21
End date: 2007-03-21
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Fistulogram
Start date: 1999-10-08
End date: 1999-10-08
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-13
End date: 1999-10-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-04
End date: 2006-02-04
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-09-27
End date: 1999-09-27
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-03-19
End date: 2008-03-19
Other drugs received by patient: Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renvela; Phoslo; Calcium Acetate; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Acetaminophen and Hydrocodone Bitartrate; Iron; Sensipar; Aspirin
Possible Optimark side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-11
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Renal Disorder, Pain, General Physical Health Deterioration, Skin Disorder, Nephrogenic Systemic Fibrosis, Rash, Discomfort, Emotional Distress, Anxiety, Major Depression, Injury, Mobility Decreased, Immobile
Drug(s) suspected as cause:
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 19 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-21
End date: 2008-07-21
Magnevist
Indication: Asthenia
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-21
End date: 2005-05-21
Gadolinium IN Unspecified Drug
Indication: Angiogram
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Dizziness
Start date: 2006-10-23
End date: 2006-10-23
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-11
End date: 2005-08-11
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Metoprolol Tartrate; Lyrica; Dexamethasone; Actonel; Triamteren HCT; Tamsulosin HCL; Omeprazole; Simvastatin; Amiodarone HCL; Iron Sulfatethiamin Compound TAB; Benicar; Norvasc; Hydralazine HCL; Warfarin Sodium; Metformin HCL; Silodosin; Coreg; Potassium
Possible Optimark side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-09
Patient: 57 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Pruritus, Skin Hyperpigmentation, Skin Discolouration, Skin Lesion, Skin Atrophy, Muscle Spasms, Peau D'orange, Pain in Extremity, Musculoskeletal Pain, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Skin Hypertrophy, Skin Hypopigmentation, Deformity, Skin Tightness, Arthralgia, Lichenification, Xerosis, Scar
Drug(s) suspected as cause:
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Magnevist
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2004-07-09
End date: 2004-07-09
Magnevist
Multihance
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2002-05-20
End date: 2002-05-20
Prohance
Dosage: 15 ml, unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2003-01-14
End date: 2003-01-14
Prohance
Dosage: unk
Start date: 2006-10-20
End date: 2006-10-20
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2001-04-20
End date: 2001-04-20
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-05-24
End date: 2006-05-24
Other drugs received by patient: Ambien; Antiglaucoma Preparations and Miotics; Phenazopyridine HCL TAB; Tigan; MS Contin; Vibramycin; Lorcet-HD; MS Contin; Percocet; Xalatan; Antiglaucoma Preparations and Miotics; Antivert; Celexa; Augmentin '125'; Protonix; Ciprofloxacin HCL; Bactrim DS; Symbicort; Effexor; Mucinex; Depo; Orapred; Morphine Sulfate; Pyridiate; Singulair; Hycodan; Oxycontin; Combivent
Possible Optimark side effects in 45 year old male
Reported by a consumer/non-health professional from United States on 2012-04-05
Patient: 45 year old male, weighing 88.3 kg (194.4 pounds)
Reactions: Transplant Failure, Muscle Atrophy, Contusion, Hyperkalaemia, Unresponsive To Stimuli, Clostridium Difficile Colitis, Treatment Noncompliance, Balance Disorder, Oedema Peripheral, Blood Pressure Inadequately Controlled, Muscle Spasms, Ventricular Extrasystoles, Back Pain, Pneumonia, Cellulitis, Pain in Extremity, Renal Cancer, General Physical Health Deterioration, Lumbar Radiculopathy, Nephrogenic Systemic Fibrosis, Haemodialysis, Emotional Distress, Major Depression, Cholecystectomy, Mobility Decreased, Pain, Pallor, Pericardial Excision, Fall, Myalgia, Injury, Myocardial Infarction, Gouty Arthritis, Muscular Weakness, Rash, Discomfort, Anxiety, Sepsis, Gait Disturbance, Cardiac Arrest
Drug(s) suspected as cause:
Magnevist
Indication: Angiogram
Start date: 2007-02-05
End date: 2007-02-05
Omniscan
Indication: Product Used FOR Unknown Indication
Prohance
Indication: Product Used FOR Unknown Indication
Multihance
Indication: Product Used FOR Unknown Indication
Optimark
Indication: Product Used FOR Unknown Indication
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Start date: 2002-11-20
End date: 2002-11-20
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Other drugs received by patient: Iron Supplement; Plavix; Lipitor; Nifedipine; Hydralazine HCL; Alprazolam; Procardia; Coumadin; Epogen; Immunosuppressive Agents; Restoril; Multi-Vitamin; Digoxin; Prednisone 50mg TAB; Coreg; Neoral; Heart Medication (Nos); Amiodarone HCL; Effexor; Coumadin; Prednisone 50mg TAB; Hydrocodone; Lipitor; Lasix
Possible Optimark side effects in
Reported by a lawyer from United States on 2012-04-03
Patient:
Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Mobility Decreased, Scar
Drug(s) suspected as cause:
Magnevist
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Possible Optimark side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-27
Patient: 54 year old male, weighing 93.9 kg (206.5 pounds)
Reactions: Gastrointestinal Haemorrhage, Hyperkeratosis, Morphoea, Pain, Erythema, Gastritis, Hand Deformity, Skin Discolouration, Oedema Peripheral, Lipoma, Emotional Disorder, Skin Swelling, Tendonitis, Haemorrhoids, Rash Papular, General Physical Health Deterioration, Patellofemoral Pain Syndrome, Nephrogenic Systemic Fibrosis, DRY Skin, Skin Induration, Skin Hypertrophy, Renal Failure Chronic, Deformity, Skin Tightness, Haemodialysis, Sclerodactylia, Osteoarthritis, Mental Disorder
Drug(s) suspected as cause:
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 1999-09-20
End date: 1999-09-20
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2007-03-21
End date: 2007-03-21
Magnevist
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-02-04
End date: 2006-02-04
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-11-18
End date: 2008-11-18
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2006-01-14
End date: 2006-01-14
Omniscan
Indication: Nuclear Magnetic Resonance Imaging
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Nuclear Magnetic Resonance Imaging
Start date: 1999-09-27
End date: 1999-09-27
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Fistulogram
Start date: 1999-10-08
End date: 1999-10-08
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-13
End date: 1999-10-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-08-13
End date: 2008-08-13
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 1999-10-28
End date: 1999-10-28
Gadolinium IN Unspecified Drug
Dosage: unk
Start date: 2008-03-19
End date: 2008-03-19
Other drugs received by patient: Calcium Acetate; Acetaminophen and Hydrocodone Bitartrate; Aspirin; Phoslo; Sensipar; Renal [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Rena-Vite [vit C,vit H,b5,b12,b9,b3,b6,b2,b1 Hcl]; Renvela; Iron
Possible Optimark side effects in male
Reported by a physician from United States on 2012-03-27
Patient: male, weighing 86.0 kg (189.2 pounds)
Reactions: Renal Disorder, Pain, Skin Disorder, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Rash, Discomfort, Anxiety, Emotional Distress, Major Depression, Injury, Immobile, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Indication: Nuclear Magnetic Resonance Imaging Abdominal
Gadolinium IN Unspecified Drug
Dosage: unk
Indication: Dizziness
Start date: 2006-10-23
End date: 2006-10-23
Gadolinium IN Unspecified Drug
Indication: Angiogram
Optimark
Indication: Nuclear Magnetic Resonance Imaging
Prohance
Indication: Nuclear Magnetic Resonance Imaging
Magnevist
Dosage: 19 ml, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2008-07-21
End date: 2008-07-21
Magnevist
Indication: Asthenia
Omniscan
Dosage: unk, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2005-08-11
End date: 2005-08-11
Multihance
Indication: Nuclear Magnetic Resonance Imaging
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Nuclear Magnetic Resonance Imaging
Start date: 2005-05-21
End date: 2005-05-21
Other drugs received by patient: Actonel; Metoprolol Succinate; Benicar; Norvasc; Hydralazine HCL; Tamsulosin HCL; Iron Sulfatethiamin Compound TAB; Potassium; Triamteren HCT; Amiodarone HCL; Dexamethasone; Omeprazole; Lyrica; Silodosin; Metformin HCL; Simvastatin; Coreg; Warfarin Sodium
Possible Optimark side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26
Patient: 56 year old female
Reactions: Pain, Abasia, Anhedonia, Joint Range of Motion Decreased, Oedema Peripheral, Fibrosis, Depression, Injury, General Physical Health Deterioration, Muscular Weakness, Nephrogenic Systemic Fibrosis, DRY Skin, Deformity, Anxiety, Emotional Distress, Arthralgia, Scar, Mobility Decreased
Drug(s) suspected as cause:
Magnevist
Dosage: unk
Indication: Renal Mass
Start date: 2004-05-21
End date: 2004-05-21
Optimark
Indication: Muscular Weakness
Optimark
Indication: Headache
Optimark
Dosage: 15 ml, once
Indication: Nuclear Magnetic Resonance Imaging Brain
Start date: 2006-06-02
End date: 2006-06-02
Optimark
Indication: Disorientation
Magnevist
Other drugs received by patient: Sensipar; Prograf; Prednisone TAB; Atenolol; Renvela; Lantus
Possible Optimark side effects in
Reported by a lawyer from United States on 2012-03-22
Patient:
Reactions: Pain, General Physical Health Deterioration, Fibrosis, Nephrogenic Systemic Fibrosis, Deformity, Mobility Decreased, Scar
Drug(s) suspected as cause:
Prohance
Indication: Imaging Procedure
Magnevist
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Possible Optimark side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-20
Patient: male, weighing 74.3 kg (163.5 pounds)
Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Deformity, Oedema Peripheral, Fibrosis, Mobility Decreased, Scar
Drug(s) suspected as cause:
Prohance
Indication: Imaging Procedure
Magnevist
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Omniscan
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Gadolinium IN Unspecified Drug
Dosage: unk unk, once
Indication: Vascular Graft
Start date: 2010-05-10
End date: 2010-05-10
Other drugs received by patient: Metoprolol Tartrate; Fexofenadine Hydrochloride; Ventolin HFA; Glipizide; Slow-K; Amlodipine Besylate; Singulair; Protonix; Doxycycline AL; Isosorbide Dinitrate, Combinations; Lasix; Nitroglycerin; Pantoprazole; Vytorin; Nasonex; Simvastatin; Advair Diskus 100 / 50; Renvela; Multi-Vitamins; Atrovent; Tramadol HCL CF; Analgesics; Januvia; Clonidine; Prednisone; Coreg; Hyflex-DS
Possible Optimark side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-20
Patient: female
Reactions: Pain, General Physical Health Deterioration, Nephrogenic Systemic Fibrosis, Fibrosis, Deformity, Scar, Mobility Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Omniscan
Indication: Imaging Procedure
Prohance
Indication: Imaging Procedure
Magnevist
Indication: Imaging Procedure
Optimark
Indication: Imaging Procedure
Multihance
Indication: Imaging Procedure
Page 1 Next >>
|